世界の糖尿病性眼科疾患治療市場2021年-2028年:市場規模、シェア、動向分析

Grand View Researchが発行した調査報告書(GV21OT052)
◆英語タイトル:Diabetes Associated Ophthalmic Treatment Market Size, Share & Trends Analysis Report By Type (Drugs, Devices), By Application (Dry Eye, Glaucoma, Diabetic Retinopathy, DAMD, Uveitis, Cataract), By End-use, By Region, And Segment Forecasts, 2021 - 2028
◆商品コード:GV21OT052
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年10月13日
◆ページ数:178
◆レポート形式:英語 / PDF
◆納品方法:Eメール(3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥684,250見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥799,250見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,029,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。

グランドビューリサーチ社は、糖尿病性眼科疾患治療の世界市場規模が2028年までに447億ドルに達すると予測しています。2021年から2028年までの間に年平均6.5%成長する見通しです。本調査資料は、世界の糖尿病性眼科疾患治療市場について調査し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、用途別(ドライアイ症候群、緑内障、眼アレルギー・感染症、糖尿病性網膜症、糖尿病性黄斑)分析、種類別(医薬品、デバイス)分析、最終用途別(病院、眼科センター、外来手術センター、その他)分析、地域別分析、競争分析などの項目を掲載しています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・糖尿病性眼科疾患治療の世界市場規模:用途別(ドライアイ症候群、緑内障、眼アレルギー・感染症、糖尿病性網膜症、糖尿病性黄斑)
・糖尿病性眼科疾患治療の世界市場規模:種類別(医薬品、デバイス)
・糖尿病性眼科疾患治療の世界市場規模:最終用途別(病院、眼科センター、外来手術センター、その他)
・糖尿病性眼科疾患治療の世界市場規模:地域別
・競争分析
【レポートの概要】

Diabetes Associated Ophthalmic Treatment Market Growth & Trends

The global diabetes associated ophthalmic treatment market size is expected to reach USD 44.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.5% from 2021 to 2028. The increasing prevalence of type II diabetes, geriatric population, and availability of early detection techniques are some of the factors driving the growth. This is coupled with technological advancements and increasing awareness of early diagnostics to help increase the success rate of the available treatment options. An increasing number of clinical trials to assess new drugs and devices for the prevention and management of these ophthalmic conditions are expected to fuel market growth in upcoming years.

COVID-19 related diabetic and ophthalmic complications are expected to boost the market for diabetes associated ophthalmic treatment methods. COVID-19 has a long-term effect on diabetic conditions. This is expected to increase the demand for treatment procedures in upcoming years. An increasing number of initiatives being undertaken by governments and nonprofit organizations to increase diabetes associated ophthalmic disease awareness is expected to boost the adoption of devices used for the treatment. Furthermore, WHO and IDF are working together to prevent and control diabetes and ensure good quality of life for people worldwide by providing accessible treatment facilities.

Diabetes Associated Ophthalmic Treatment Market Report Highlights

• The diabetic retinopathy segment has captured the largest revenue share in 2020 followed by diabetic associated macular degeneration and glaucoma

• The drugs segment dominated the market and accounted for the highest revenue share in 2020 owing to factors such as the presence of major key players operating in the global market, high adoption rate, increased clinical trials to develop innovative drugs

• The hospitals segment is predicted to witness the fastest growth rate over the forecast timeframe due to the increasing number of patient visits and advanced infrastructure in hospitals as compared to other healthcare facilities. An increasing number of hospital admissions of diabetes patients is boosting the demand for the segment, thereby propelling the growth

• North America held the largest revenue share in the market and is expected to maintain its dominance over the forecast period

【レポートの目次】

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Application
1.1.2 Type
1.1.3 End-use
1.1.4 Regional Scope
1.1.5 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for Primary Interviews in Europe
1.3.5.3 Data for Primary Interviews in APAC
1.3.5.4 Data for Primary Interviews in Latin America
1.3.5.5 Data for Primary Interviews in MEA
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
1.9.3 Objective 3
1.9.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Diabetes Associated Ophthalmic Treatment Market Variables, Trends & Scope
3.1 Penetration & Growth Prospect Mapping
3.2 Market Dynamics
3.2.1 Market Drivers Analysis
3.2.1.1 Increasing prevalence of diabetes
3.2.1.2 Advancements in the technology for efficient treatment
3.2.1.3 Increasing governments initiatives
3.2.2 Market Restraint Analysis
3.2.2.1 Lack of skilled ophthalmologists
3.2.3 Market Opportunity Analysis
3.2.3.1 Increasing demand for diabetic ophthalmic diseases treatment to avoid visual impairment
3.3 Diabetes Associated Ophthalmic Treatment: Market Analysis Tools
3.3.1 SWOT Analysis by PESTEL
3.3.2 Industry Analysis-Porter’s
3.4 Impact of COVID-19
3.4.1 COVID-19 Impact analysis
3.4.2 Impact on market players
Chapter 4 Diabetes Associated Ophthalmic Treatment Market: Segment Analysis, By Application, 2017 – 2028 (USD Million)
4.1 Definitions and Scope
4.2 Application Market Share Analysis
4.3 Segment Dashboard
4.4 Diabetes Associated Ophthalmic Treatment Market by Application
4.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028 for the following
4.5.1 Dry Eye Syndrome
4.5.1.1 Dry Eye Syndrome Market Estimates and Forecast, 2017 – 2028 (USD Million)
4.5.2 Glaucoma
4.5.2.1 Glaucoma Market Estimates and Forecast, 2017 – 2028 (USD Million)
4.5.3 Eye Allergy & Infection
4.5.3.1 Eye Allergy & Infection Market Estimates and Forecast, 2017 – 2028 (USD Million)
4.5.4 Diabetic Retinopathy
4.5.4.1 Diabetic Retinopathy Market Estimates and Forecast, 2017 – 2028 (USD Million)
4.5.5 Diabetic associated Macular Degeneration
4.5.5.1 Diabetic associated Macular Degeneration Market Estimates and Forecast, 2017 – 2028 (USD Million)
4.5.6 Uveitis
4.5.6.1 Uveitis Market Estimates and Forecast, 2017 – 2028 (USD Million)
4.5.7 Cataract
4.5.7.1 Cataract Market Estimates and Forecast, 2017 – 2028 (USD Million)
4.5.8 Diabetic Macular Edema
4.5.8.1 Diabetic Macular Edema Market Estimates and Forecast, 2017 – 2028 (USD Million)
4.5.9 Others
4.5.9.1 Others Market Estimates and Forecast, 2017 – 2028 (USD Million)
Chapter 5 Diabetes Associated Ophthalmic Treatment Market: Segment Analysis, By Type, 2017 – 2028 (USD Million)
5.1 Definitions and Scope
5.2 Type Market Share Analysis
5.3 Segment Dashboard
5.4 Diabetes Associated Ophthalmic Treatment Market by Type
5.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028 for the following
5.5.1 Drugs
5.5.1.1 Drugs Market Estimates and Forecast, 2017 – 2028 (USD Million)
5.5.2 Devices
5.5.2.1 Devices Market Estimates and Forecast, 2017 – 2028 (USD Million)
Chapter 6 Diabetes Associated Ophthalmic Treatment Market: Segment Analysis, By End-use, 2017 – 2028 (USD Million)
6.1 Definitions and Scope
6.2 End-use Market Share Analysis
6.3 Segment Dashboard
6.4 Diabetes Associated Ophthalmic Treatment Market by End-use
6.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028 for the following
6.5.1 Hospitals
6.5.1.1 Hospitals Market Estimates and Forecast, 2017 – 2028 (USD Million)
6.5.2 Ophthalmic Centers
6.5.2.1 Ophthalmic Centers Market Estimates and Forecast, 2017 – 2028 (USD Million)
6.5.3 Ambulatory Surgery Centers (ASCs)
6.5.3.1 Ambulatory Surgery Centers Market Estimates and Forecast, 2017 – 2028 (USD Million)
6.5.4 Others
6.5.4.1 Others Market Estimates and Forecast, 2017 – 2028 (USD Million)
Chapter 7 Diabetes Associated Ophthalmic Treatment Market: Regional Market Analysis, 2017 – 2028 (USD Million)
7.1 Regional Market Dashboard
7.2 Definitions and Scope
7.3 Regional Market Share Analysis
7.4 North America
7.4.1 North America Market estimates and forecast, 2017 – 2028
7.4.2 U.S.
7.4.2.1 U.S. market estimates and forecast, 2017 – 2028
7.4.3 Canada
7.4.3.1 Canada market estimates and forecast, 2017 – 2028
7.5 Europe
7.5.1 Europe market estimates and forecast, 2017 – 2028
7.5.2 U.K.
7.5.2.1 U.K. market estimates and forecast, 2017 – 2028
7.5.3 Germany
7.5.3.1 Germany market estimates and forecast, 2017 – 2028
7.5.4 France
7.5.4.1 France market estimates and forecast, 2017 – 2028
7.5.5 Italy
7.5.5.1 Italy market estimates and forecast, 2017 – 2028
7.5.6 Spain
7.5.6.1 Spain market estimates and forecast, 2017 – 2028
7.6 Asia Pacific
7.6.1 Asia Pacific market estimates and forecast, 2017 – 2028
7.6.2 India
7.6.2.1 India market estimates and forecast, 2017 – 2028
7.6.3 Japan
7.6.3.1 Japan Market estimates and forecast, 2017 – 2028
7.6.4 China
7.6.4.1 China Market estimates and forecast, 2017 – 2028
7.6.5 Australia
7.6.5.1 Australia Market estimates and forecast, 2017 – 2028
7.6.6 South Korea
7.6.6.1 South Korea Market estimates and forecast, 2017 – 2028
7.7 Latin America
7.7.1 Latin America market estimates and forecast, 2017 – 2028
7.7.2 Mexico
7.7.2.1 Mexico Market estimates and forecast, 2017 – 2028
7.7.3 Brazil
7.7.3.1 Brazil market estimates and forecast, 2017 – 2028
7.7.4 Argentina
7.7.4.1 Argentina market estimates and forecast, 2017 – 2028
7.7.5 Colombia
7.7.5.1 Colombia market estimates and forecast, 2017 – 2028
7.8 Middle East and Africa
7.8.1 Middle East and Africa Market estimates and forecast, 2017 – 2028
7.8.2 South Africa
7.8.2.1 South Africa market estimates and forecast, 2017 – 2028
7.8.3 Saudi Arabia
7.8.3.1 Saudi Arabia market estimates and forecast, 2017 – 2028
7.8.4 UAE
7.8.4.1 UAE market estimates and forecast, 2017 – 2028
Chapter 8 Diabetes Associated Ophthalmic Treatment Market – Competitive Analysis
8.1 Kind of Competition
8.2 Concentration of Market Players
8.3 Company Market Share Analysis
8.4 Categorization based on the Company’s Vision
8.5 Company Profiles
8.5.1 Medtronic
8.5.1.1 Company overview
8.5.1.2 Financial performance
8.5.1.3 Product benchmarking
8.5.1.4 Strategic initiatives
8.5.2 Alcon
8.5.2.1 Company overview
8.5.2.2 Financial performance
8.5.2.3 Product benchmarking
8.5.2.4 Strategic initiatives
8.5.3 Johnson & Johnson Services, Inc.
8.5.3.1 Company overview
8.5.3.2 Financial performance
8.5.3.3 Product benchmarking
8.5.3.4 Strategic initiatives
8.5.4 Bausch Health
8.5.4.1 Company overview
8.5.4.2 Financial performance
8.5.4.3 Product benchmarking
8.5.4.4 Strategic initiatives
8.5.5 Allergan
8.5.5.1 Company overview
8.5.5.2 Financial performance
8.5.5.3 Product benchmarking
8.5.5.4 Strategic initiatives
8.5.6 Bayer AG
8.5.6.1 Company overview
8.5.6.2 Financial performance
8.5.6.3 Product benchmarking
8.5.6.4 Strategic initiatives
8.5.7 Santen Pharmaceutical Co. Ltd.
8.5.7.1 Company overview
8.5.7.2 Financial performance
8.5.7.3 Product benchmarking
8.5.7.4 Strategic initiatives
8.5.8 Novartis AG
8.5.8.1 Company overview
8.5.8.2 Financial performance
8.5.8.3 Product benchmarking
8.5.8.4 Strategic initiatives
8.5.9 Pfizer, Inc.
8.5.9.1 Company overview
8.5.9.2 Financial performance
8.5.9.3 Product benchmarking
8.5.9.4 Strategic initiatives
8.5.10 Genentech, Inc.
8.5.10.1 Company overview
8.5.10.2 Financial performance
8.5.10.3 Product benchmarking
8.5.10.4 Strategic initiatives
8.5.11 Carl Zeiss Meditec
8.5.11.1 Company overview
8.5.11.2 Financial performance
8.5.11.3 Product benchmarking
8.5.11.4 Strategic initiatives
8.5.12 Lumenis
8.5.12.1 Company overview
8.5.12.2 Financial performance
8.5.12.3 Product benchmarking
8.5.12.4 Strategic initiatives
8.5.13 Ellex Medical Lasers Ltd.
8.5.13.1 Company overview
8.5.13.2 Financial performance
8.5.13.3 Product benchmarking
8.5.13.4 Strategic initiatives
8.5.14 IRIDEX Corporation
8.5.14.1 Company overview
8.5.14.2 Financial performance
8.5.14.3 Product benchmarking
8.5.14.4 Strategic initiatives
8.5.15 Topcon Corporation
8.5.15.1 Company overview
8.5.15.2 Financial performance
8.5.15.3 Product benchmarking
8.5.15.4 Strategic initiatives
8.5.16 Abbott Medical Optics
8.5.16.1 Company overview
8.5.16.2 Financial performance
8.5.16.3 Product benchmarking
8.5.16.4 Strategic initiatives
8.5.17 Quantel
8.5.17.1 Company overview
8.5.17.2 Financial performance
8.5.17.3 Product benchmarking
8.5.17.4 Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America diabetes associated ophthalmic treatment market, by Region, 2017 - 2028 (USD Million)
Table 3 North America diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 4 North America diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 5 North America diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)
Table 6 U.S. diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 7 U.S. diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 8 U.S. diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)
Table 9 Canada diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 10 Canada diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 11 Canada diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)
Table 12 Europe diabetes associated ophthalmic treatment market, by Region, 2017 - 2028 (USD Million)
Table 13 Europe diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 14 Europe diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 15 Europe diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)
Table 16 Germany diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 17 Germany diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 18 Germany diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)
Table 19 U.K. diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 20 U.K. diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 21 U.K. diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)
Table 22 France diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 23 France diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 24 France diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)
Table 25 Italy diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 26 Italy diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 27 Italy diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)
Table 28 Spain diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 29 Spain diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 30 Spain diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)
Table 31 APAC diabetes associated ophthalmic treatment market, by Region, 2017 - 2028 (USD Million)
Table 32 APAC diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 33 APAC diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 34 APAC diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)
Table 35 China diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 36 China diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 37 China diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)
Table 38 Japan diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 39 Japan diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 40 Japan diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)
Table 41 India diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 42 India diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 43 India diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)
Table 44 Australia diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 45 Australia diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 46 Australia diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)
Table 47 South Korea diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 48 South Korea diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 49 South Korea diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)
Table 50 Latin America diabetes associated ophthalmic treatment market, by Region, 2017 - 2028 (USD Million)
Table 51 Latin America diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 52 Latin America diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 53 Latin America diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)
Table 54 Brazil diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 55 Brazil diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 56 Brazil diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)
Table 57 Mexico diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 58 Mexico diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 59 Mexico diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)
Table 60 Argentina diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 61 Argentina diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 62 Argentina diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)
Table 63 Colombia diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 64 Colombia diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 65 Colombia diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)
Table 66 Middle East and Africa diabetes associated ophthalmic treatment market, by Region, 2017 - 2028 (USD Million)
Table 67 Middle East and Africa diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 68 Middle East and Africa diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 69 Middle East and Africa diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)
Table 70 South Africa diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 71 South Africa diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 72 South Africa diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)
Table 73 Saudi Arabia diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 74 Saudi Arabia diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 75 Saudi Arabia diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)
Table 76 UAE diabetes associated ophthalmic treatment market, by Application, 2017 - 2028 (USD Million)
Table 77 UAE diabetes associated ophthalmic treatment market, by Type, 2017 - 2028 (USD Million)
Table 78 UAE diabetes associated ophthalmic treatment market, by End-use, 2017 - 2028 (USD Million)


List of Figure

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Diabetes associated ophthalmic treatment market: market outlook
Fig. 14 Diabetes associated ophthalmic treatment market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Diabetes associated ophthalmic treatment market driver impact
Fig. 20 Diabetes associated ophthalmic treatment market restraint impact
Fig. 21 Diabetes associated ophthalmic treatment market strategic initiatives analysis
Fig. 22 Diabetes associated ophthalmic treatment market: Application movement analysis
Fig. 23 Diabetes associated ophthalmic treatment market: Application outlook and key takeaways
Fig. 24 Dry eye syndrome market estimates and forecast, 2017 - 2028
Fig. 25 Glaucoma market estimates and forecast, 2017 - 2028
Fig. 26 Eye allergy & infection market estimates and forecast, 2017 - 2028
Fig. 27 Diabetic retinopathy market estimates and forecast, 2017 - 2028
Fig. 28 Diabetic associated macular degeneration market estimates and forecast, 2017 - 2028
Fig. 29 Uveitis market estimates and forecast, 2017 - 2028
Fig. 30 Cataract market estimates and forecast, 2017 - 2028
Fig. 31 Diabetic macular edema market estimates and forecast, 2017 - 2028
Fig. 32 Other market estimates and forecast, 2017 - 2028
Fig. 33 Diabetes associated ophthalmic treatment market: Type movement analysis
Fig. 34 Diabetes associated ophthalmic treatment market: Type outlook and key takeaways
Fig. 35 Drugs market estimates and forecast, 2017 - 2028
Fig. 36 Devices market estimates and forecast, 2017 - 2028
Fig. 37 Diabetes associated ophthalmic treatment market: end-use movement analysis
Fig. 38 Diabetes associated ophthalmic treatment market: end-use outlook and key takeaways
Fig. 39 Hospitals market estimates and forecast, 2017 - 2028
Fig. 40 Ophthalmic Centers market estimates and forecast, 2017 - 2028
Fig. 41 Ambulatory surgical centers market estimates and forecast, 2017 - 2028
Fig. 42 Global diabetes associated ophthalmic treatment market: Regional movement analysis
Fig. 43 Global diabetes associated ophthalmic treatment market: Regional outlook and key takeaways
Fig. 44 Global market shares and leading players
Fig. 45 North America market share and leading players
Fig. 46 Europe market share and leading players
Fig. 47 Asia Pacific market share and leading players
Fig. 48 Latin America market share and leading players
Fig. 49 Middle East & Africa market share and leading players
Fig. 50 North America: SWOT
Fig. 51 Europe SWOT
Fig. 52 Asia Pacific SWOT
Fig. 53 Latin America SWOT
Fig. 54 MEA SWOT
Fig. 55 North America, by country
Fig. 56 North America
Fig. 57 North America market estimates and forecast, 2017 - 2028
Fig. 58 U.S.
Fig. 59 U.S. market estimates and forecast, 2017 - 2028
Fig. 60 Canada
Fig. 61 Canada market estimates and forecast, 2017 - 2028
Fig. 62 Europe
Fig. 63 Europe. market estimates and forecast, 2017 - 2028
Fig. 64 U.K.
Fig. 65 U.K. market estimates and forecast, 2017 - 2028
Fig. 66 Germany
Fig. 67 Germany market estimates and forecast, 2017 - 2028
Fig. 68 France
Fig. 69 France market estimates and forecast, 2017 - 2028
Fig. 70 Italy
Fig. 71 Italy market estimates and forecast, 2017 - 2028
Fig. 72 Spain
Fig. 73 Spain market estimates and forecast, 2017 - 2028
Fig. 74 Asia Pacific
Fig. 75 Asia Pacific market estimates and forecast, 2017 - 2028
Fig. 76 China
Fig. 77 China market estimates and forecast, 2017 - 2028
Fig. 78 Japan
Fig. 79 Japan market estimates and forecast, 2017 - 2028
Fig. 80 India
Fig. 81 India market estimates and forecast, 2017 - 2028
Fig. 82 Australia
Fig. 83 Australia market estimates and forecast, 2017 - 2028
Fig. 84 South Korea
Fig. 85 South Korea market estimates and forecast, 2017 - 2028
Fig. 86 Latin America
Fig. 87 Latin America market estimates and forecast, 2017 - 2028
Fig. 88 Brazil
Fig. 89 Brazil market estimates and forecast, 2017 - 2028
Fig. 90 Mexico
Fig. 91 Mexico market estimates and forecast, 2017 - 2028
Fig. 92 Argentina
Fig. 93 Argentina market estimates and forecast, 2017 - 2028
Fig. 94 Colombia
Fig. 95 Colombia market estimates and forecast, 2017 - 2028
Fig. 96 Middle East and Africa
Fig. 97 Middle East and Africa. market estimates and forecast, 2017 - 2028
Fig. 98 Saudi Arabia
Fig. 99 Saudi Arabia market estimates and forecast, 2017 - 2028
Fig. 100 South Africa
Fig. 101 South Africa market estimates and forecast, 2017 - 2028
Fig. 102 UAE
Fig. 103 UAE market estimates and forecast, 2017 - 2028
Fig. 104 Participant categorization- diabetes associated ophthalmic treatment market
Fig. 105 Market share of key market players- diabetes associated ophthalmic treatment market

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の糖尿病性眼科疾患治療市場2021年-2028年:市場規模、シェア、動向分析(Diabetes Associated Ophthalmic Treatment Market Size, Share & Trends Analysis Report By Type (Drugs, Devices), By Application (Dry Eye, Glaucoma, Diabetic Retinopathy, DAMD, Uveitis, Cataract), By End-use, By Region, And Segment Forecasts, 2021 - 2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆